| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC0741 |
| Trial ID | ChiCTR1800016584 |
| Disease | B-Cell Malignancy |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Targeting CD19 chimeric antigen receptor gene modified autologous T cells (CD19 CAR-T) for the treatment of CD19 positive recurrent and refractory B cell malignancies |
| Year | 2018 |
| Country | China |
| Company sponsor | Nanjing Gulou Hosptial |
| Cohort 1 | |||||||||
|
|||||||||